These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34376526)

  • 1. Associations between GDF15 levels and pre-diabetes in non-obese subjects.
    Hung HC; Wu HT; Lin CH; Chou HW; Ou HY; Chang CJ
    J Investig Med; 2022 Jan; 70(1):79-84. PubMed ID: 34376526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lipid and hsCRP levels in prediabetes--impaired fasting glucose (IFG) and impaired glucose tolerance (IGT).
    Chakarova N; Tankova T; Atanassova I; Dakovska L
    Diabetes Res Clin Pract; 2009 Oct; 86(1):56-60. PubMed ID: 19674805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased arterial stiffness in subjects with impaired glucose tolerance and newly diagnosed diabetes but not isolated impaired fasting glucose.
    Li CH; Wu JS; Yang YC; Shih CC; Lu FH; Chang CJ
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E658-62. PubMed ID: 22337914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired baroreflex sensitivity in subjects with impaired glucose tolerance, but not isolated impaired fasting glucose.
    Wu JS; Lu FH; Yang YC; Chang SH; Huang YH; Chen JJ; Chang CJ
    Acta Diabetol; 2014 Aug; 51(4):535-41. PubMed ID: 24408773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between impaired fasting glucose and self-reported sleep quality in a Chinese population.
    Hung HC; Yang YC; Ou HY; Wu JS; Lu FH; Chang CJ
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):518-24. PubMed ID: 22548278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action.
    Faerch K; Vaag A; Holst JJ; Glümer C; Pedersen O; Borch-Johnsen K
    Diabetologia; 2008 May; 51(5):853-61. PubMed ID: 18317726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
    Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression from optimal blood glucose and pre-diabetes to type 2 diabetes in a high risk population with or without hypertension in Isfahan, Iran.
    Janghorbani M; Amini M
    Diabetes Res Clin Pract; 2015 Jun; 108(3):414-22. PubMed ID: 25814432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From pre-diabetes to type 2 diabetes in obese youth: pathophysiological characteristics along the spectrum of glucose dysregulation.
    Bacha F; Lee S; Gungor N; Arslanian SA
    Diabetes Care; 2010 Oct; 33(10):2225-31. PubMed ID: 20592052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study.
    Faerch K; Vaag A; Holst JJ; Hansen T; Jørgensen T; Borch-Johnsen K
    Diabetes Care; 2009 Mar; 32(3):439-44. PubMed ID: 19056613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal glycemic profiles by CGMS in obese first-degree relatives of type 2 diabetes mellitus patients.
    Madhu SV; Muduli SK; Avasthi R
    Diabetes Technol Ther; 2013 Jun; 15(6):461-5. PubMed ID: 23631606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes.
    Ou HY; Yang YC; Wu HT; Wu JS; Lu FH; Chang CJ
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):450-5. PubMed ID: 21521338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
    Kanat M; Norton L; Winnier D; Jenkinson C; DeFronzo RA; Abdul-Ghani MA
    Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin E and mast cell proteases are potential risk factors of impaired fasting glucose and impaired glucose tolerance in humans.
    Wang Z; Zhang H; Shen XH; Jin KL; Ye GF; Qiu W; Qian L; Li B; Zhang YH; Shi GP
    Ann Med; 2013 May; 45(3):220-9. PubMed ID: 23110545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China.
    Zhang F; Wan Q; Cao H; Tang L; Li D; Lü Q; Yan Z; Li J; Yang Q; Zhang Y; Tong N
    BMJ Open; 2018 May; 8(5):e019735. PubMed ID: 29743321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired secretion of total glucagon-like peptide-1 in people with impaired fasting glucose combined impaired glucose tolerance.
    Zhang F; Tang X; Cao H; Lü Q; Li N; Liu Y; Zhang X; Zhang Y; Cao M; Wan J; An Z; Tong N
    Int J Med Sci; 2012; 9(7):574-81. PubMed ID: 22991496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum fibroblast growth factor 19 levels are decreased in Chinese subjects with impaired fasting glucose and inversely associated with fasting plasma glucose levels.
    Fang Q; Li H; Song Q; Yang W; Hou X; Ma X; Lu J; Xu A; Jia W
    Diabetes Care; 2013 Sep; 36(9):2810-4. PubMed ID: 23628619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired insulin sensitivity is accompanied by disturbances in skeletal muscle fatty acid handling in subjects with impaired glucose metabolism.
    Moors CC; van der Zijl NJ; Diamant M; Blaak EE; Goossens GH
    Int J Obes (Lond); 2012 May; 36(5):709-17. PubMed ID: 21712806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of C-reactive protein levels with fasting and postload glucose levels according to glucose tolerance status.
    Guerrero-Romero F; Simental-Mendía LE; Rodríguez-Morán M
    Arch Med Res; 2014 Jan; 45(1):70-5. PubMed ID: 24326321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.